New Research Insights to be Presented by Invitae at the 2023 ASCO Annual Meeting Reinforce the Critical Role of Germline Genetic Testing in Oncology

– Study findings confirm the importance of improving education among clinicians and streamlining processes to increase adoption of testing in routine cancer care – SAN FRANCISCO, May 26, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced nine…